BRIGHTCOVE (BCOV)

US10921T1016 - Common Stock

3.19  +0.18 (+5.98%)

Fundamental Rating

3

Overall BCOV gets a fundamental rating of 3 out of 10. We evaluated BCOV against 83 industry peers in the IT Services industry. While BCOV seems to be doing ok healthwise, there are quite some concerns on its profitability. BCOV has a expensive valuation and it also scores bad on growth.



3

1. Profitability

1.1 Basic Checks

In the past year BCOV was profitable.
BCOV had a positive operating cash flow in the past year.
In the past 5 years BCOV reported 4 times negative net income.
BCOV had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

BCOV has a Return On Assets (-4.04%) which is comparable to the rest of the industry.
BCOV has a Return On Equity (-9.06%) which is in line with its industry peers.
Industry RankSector Rank
ROA -4.04%
ROE -9.06%
ROIC N/A
ROA(3y)-4.02%
ROA(5y)-5.56%
ROE(3y)-9.19%
ROE(5y)-12.88%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BCOV's Gross Margin of 61.36% is amongst the best of the industry. BCOV outperforms 81.71% of its industry peers.
BCOV's Gross Margin has been stable in the last couple of years.
BCOV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y0.65%

4

2. Health

2.1 Basic Checks

BCOV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BCOV has been increased compared to 1 year ago.
Compared to 5 years ago, BCOV has more shares outstanding
There is no outstanding debt for BCOV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -0.21, we must say that BCOV is in the distress zone and has some risk of bankruptcy.
BCOV has a worse Altman-Z score (-0.21) than 80.49% of its industry peers.
There is no outstanding debt for BCOV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -0.21
ROIC/WACCN/A
WACC11.12%

2.3 Liquidity

A Current Ratio of 0.73 indicates that BCOV may have some problems paying its short term obligations.
The Current ratio of BCOV (0.73) is worse than 87.80% of its industry peers.
BCOV has a Quick Ratio of 0.73. This is a bad value and indicates that BCOV is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.73, BCOV is doing worse than 87.80% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.73

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 145.45% over the past year.
BCOV shows a decrease in Revenue. In the last year, the revenue decreased by -0.22%.
BCOV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.07% yearly.
EPS 1Y (TTM)145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y0.64%
Revenue growth 5Y4.07%
Sales Q2Q%-2.02%

3.2 Future

Based on estimates for the next years, BCOV will show a decrease in Earnings Per Share. The EPS will decrease by -5.92% on average per year.
BCOV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.01% yearly.
EPS Next Y-2%
EPS Next 2Y-5.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.75%
Revenue Next 2Y0.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 63.80, BCOV can be considered very expensive at the moment.
BCOV's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 29.29, BCOV is valued quite expensively.
The Forward Price/Earnings Ratio is negative for BCOV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 63.8
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BCOV is valued a bit cheaper than 64.63% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BCOV is valued a bit more expensive than the industry average as 62.20% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 1484.5
EV/EBITDA 16.97

4.3 Compensation for Growth

BCOV's earnings are expected to decrease with -5.92% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.92%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BCOV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BRIGHTCOVE

NASDAQ:BCOV (11/22/2024, 8:25:21 PM)

3.19

+0.18 (+5.98%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap144.00M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 63.8
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.04%
ROE -9.06%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 61.36%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.73
Quick Ratio 0.73
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)145.45%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y0.64%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y